HV
8
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants
Effect of Nitrite on Exercise Physiology and Metabolism
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
Vaccine to Prevent West Nile Virus Disease
Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)
High-Density Direct Current Brain Polarization
Genetic Characterization of Parkinson's Disease
Effect of Transcranial Magnetic Stimulation on Memory